News & Insights
Expert guidance, technical deep-dives, and real-world implementation stories
The Real Work on NDC12 Is About to Start!
The transition to a 12-digit NDC is entering a new phase. Industry attention is moving beyond the rule itself and toward implementation. As organizations begin to align, areas of friction will start to emerge.
The NDC12 Final Rule Is Here
The FDA has issued the final rule revising the 12-digit National Drug Code (NDC12) format. This confirms the format and establishes a date for implementation.
NDC12 Stops Being Theory at HDA DMC
On March 10, 2026 - the NDC12 conversation moves from awareness to execution at the HDA Distribution Management Conference (DMC). Follow this blog for an overview of the session and a final recap once it's completed.
Join the Fight
Waiting on NDC12 is no longer neutral. The FDA failed to issue the final rule on NDC12. Some see this as a reason to wait. That is the wrong move.
Stood Up by the FDA. Again.
The FDA has missed its date to publish the final rule for NDC12. This heightens the risk for the industry. This article explores one option the FDA can use to extend the deadline, but it carries consequences we must understand.
New Tool: NDC12 Readiness Plan
Most organizations don’t know where NDC12 will break them. The NDC12 Readiness Assessment is a simple tool to surface risk, start the right conversations, and bring clarity to what readiness really means.
The Industry Is Ready. The NDC12 Map Isn’t.
The industry has known NDC12 was coming since 2018, yet the Final Rule remains trapped in a bureaucratic loop. Every month spent 'reviewing' is a month stolen from your implementation window. We need to stop 'waiting and seeing' and demand a date. Eric Marshall and the team at Leavitt Partners have initiated a push to expedite this; read more to see how you can join the effort.